Literature DB >> 33790977

Effect of Musk Tongxin Dropping Pill on Myocardial Remodeling and Microcirculation Dysfunction in Diabetic Cardiomyopathy.

Jingjing Zhao1,2, Yan Zhou1, Huahua Liu3, Zhaohai Zheng1,2, Shuqing Liu1,4, Jiahao Peng5, Hangyuan Guo1, Weiliang Tang1, Fang Peng1.   

Abstract

OBJECTIVE: To explore the effect of Musk Tongxin Dropping Pill (MTDP) on myocardial remodeling and microcirculation dysfunction in diabetic cardiomyopathy (DCM).
METHODS: Forty male SD rats were randomly divided into control group (control group, n = 10), DCM model group (DCM group, n = 10), DCM model + pioglitazone group (DCM + PLZ group, n = 10), and DCM model + MTDP group (DCM + MTDP group, n = 10). An intraperitoneal single injection of 65 mg/kg streptozotocin (STZ) was used to establish rat model of DCM and the rats in control group were treated with the same dose of sodium citrate buffer solution. DCM + PLZ group was treated with 3 mg/kg/d PLZ by ig after modeling, DCM + MTDP group was treated with 22 mg/kg/d MTDP by ig, and DCM group was treated with 2 ml/kg/d sodium carboxymethyl cellulose (CMC-Na) by ig. The general condition of rats was continuously observed. After intervening for 3 weeks, the random blood glucose of rats was detected by tail vein, and the echocardiography examination was performed. Blood specimens were collected from the abdominal aorta, serum nitric oxide (NO) and endothelin-1 (ET-1) were detected to estimate endothelial function, and tumor necrosis factor α (TNF-α), interleukin 6 (IL-6), IL-1β, malondialdehyde (MDA), and superoxide dismutase (SOD) were detected to observe the changes of inflammation and oxidative stress indexes. The heart mass index (HMI) was calculated through the ratio of heart mass (HM) to the corresponding body mass (BM). Myocardial pathological tissue staining was performed.
RESULTS: Compared with control group, blood glucose in other three groups was higher. Left ventricular end systolic diameter (LVSD) and left ventricular end diastolic diameter (LVDD) in DCM group showed a significant increase, while left ventricular ejection fraction (LVEF) and heart rate (HR) in this group displayed an obvious decrease (P < 0.01). BM and HM in DCM group exhibited a reduction, and HM/BM × 103 revealed an apparent increase (P < 0.01). The levels of serum NO and SOD were distinctly downregulated (P < 0.01), and the levels of ET-1, MDA, TNF-α, IL-1β, and IL-6 were remarkably upregulated (P < 0.01). Compared with DCM group, a significant decrease was observed in LVSD and LVDD in DCM + MTDP group, while LVEF and HR obviously increased (P < 0.05). BM and HM indicated an apparent increase, but HM/BM ×103 reduced distinctly (P < 0.01). The levels of serum NO and SOD were markedly upregulated (P < 0.05), and the levels of ET-1, MDA, TNF-α, IL-1β, and IL-6 were significantly downregulated (P < 0.05). HE staining showed that myocardial cells arranged neatly in the control group but not in the DCM group. The intercellular space between myocardial cells in DCM group increased, accompanied by damage of myocardial fibers and infiltration of inflammatory cells. Masson staining displayed an increase in interstitial collagen fibers in DCM group. Carstairs staining showed that microembolization occurred in the myocardium in DCM group, while in DCM + MTDP and DCM + PLZ groups the corresponding myocardial pathological changes were significantly improved.
CONCLUSIONS: MTDP might show a positive effect on myocardial remodeling and microcirculation dysfunction in DCM rats.
Copyright © 2021 Jingjing Zhao et al.

Entities:  

Year:  2021        PMID: 33790977      PMCID: PMC7997770          DOI: 10.1155/2021/6620564

Source DB:  PubMed          Journal:  Evid Based Complement Alternat Med        ISSN: 1741-427X            Impact factor:   2.629


  27 in total

1.  Diabetic cardiomyopathy in uncomplicated type 2 diabetes is associated with the metabolic syndrome and systemic inflammation.

Authors:  M Diamant; H J Lamb; J W A Smit; A de Roos; R J Heine
Journal:  Diabetologia       Date:  2005-06-30       Impact factor: 10.122

2.  Inhibition of p38 mitogen-activated protein kinase attenuates left ventricular dysfunction by mediating pro-inflammatory cardiac cytokine levels in a mouse model of diabetes mellitus.

Authors:  D Westermann; S Rutschow; S Van Linthout; A Linderer; C Bücker-Gärtner; M Sobirey; A Riad; M Pauschinger; H-P Schultheiss; C Tschöpe
Journal:  Diabetologia       Date:  2006-08-26       Impact factor: 10.122

3.  Protective effect of melatonin in the diabetic rat retina.

Authors:  Saeed Mehrzadi; Manijeh Motevalian; Mozhgan Rezaei Kanavi; Iman Fatemi; Habib Ghaznavi; Mansoor Shahriari
Journal:  Fundam Clin Pharmacol       Date:  2018-04-02       Impact factor: 2.748

Review 4.  Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways.

Authors:  Karina Huynh; Bianca C Bernardo; Julie R McMullen; Rebecca H Ritchie
Journal:  Pharmacol Ther       Date:  2014-01-22       Impact factor: 12.310

Review 5.  Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy.

Authors:  Zoltán V Varga; Zoltán Giricz; Lucas Liaudet; György Haskó; Peter Ferdinandy; Pál Pacher
Journal:  Biochim Biophys Acta       Date:  2014-07-02

6.  TNF receptor 1 signaling is critically involved in mediating angiotensin-II-induced cardiac fibrosis.

Authors:  Clemens Duerrschmid; Jeffrey R Crawford; Erin Reineke; George E Taffet; Joann Trial; Mark L Entman; Sandra B Haudek
Journal:  J Mol Cell Cardiol       Date:  2013-01-18       Impact factor: 5.000

7.  Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study.

Authors:  Giovanni de Simone; Richard B Devereux; Marcello Chinali; Elisa T Lee; James M Galloway; Ana Barac; Julio A Panza; Barbara V Howard
Journal:  J Hypertens       Date:  2010-02       Impact factor: 4.844

8.  Diabetes and cardiovascular disease. The Framingham study.

Authors:  W B Kannel; D L McGee
Journal:  JAMA       Date:  1979-05-11       Impact factor: 56.272

9.  Heart in diabetes: a microvascular disease.

Authors:  Markku Laakso
Journal:  Diabetes Care       Date:  2011-05       Impact factor: 19.112

Review 10.  Diabetic cardiomyopathy: pathophysiology and clinical features.

Authors:  Takayuki Miki; Satoshi Yuda; Hidemichi Kouzu; Tetsuji Miura
Journal:  Heart Fail Rev       Date:  2013-03       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.